SABS$3.12-5.45%
SAB Biotherapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$283.88M
Float & O/S:84.43M / 90.99M
Inst Own:75.2%
DilutionScan read 29 of SAB Biotherapeutics, Inc.'s SEC filings and found 11 warrant series, 3 convertibles, 2 ATM programs, 4 shelf registrations and 1 completed offering on file for SABS. The latest dilution event on file is an offering on Mar 19, 2026. Analysis updated Nov 4, 2026.
